Methyclothiazide

DB00232ApprovedWithdrawnSmall moleculeDiureticsSodium Chloride Symporter Inhibitors

Methyclothiazide is a diuretic drug used to treat hypertension and edema caused by heart failure, renal conditions, treatment with corticosteroids, and estrogen therapy. A thiazide diuretic with properties similar to those of hydrochlorothiazide.

Chemical structure of Methyclothiazide
Mechanism
Curator reviewed
Primary indication
For use in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.Curator reviewed · 8 structured indications
Formula / weight
C9H11Cl2N3O4S2 · 360.237 g/mol (avg)
First approval
Canada, 1960 · United States, 1961

Resolves to

Structure
InChIKeyCESYKOGBSMNBPD-UHFFFAOYSA-NSMILESCN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O

What you can answer from here — as of September 13, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,508Drug interactionsStructured to mechanism, not free text
Sign in
8Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
5Marketed productsAcross 2 countries and 4 labellers
Sign in
3ATC codesIncluding every combination product, plus 18 drug categories
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Methyclothiazide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account